Quality improvement and patient safety are inseparable in the health care industry. Medical errors can result in disability, decreased quality of life, and death. These potential outcomes underscore the need for continual system improvements and early detection of variations in hospital processes, which could precipitate adverse events. The process-based quality control methods that are becoming standard in most other professional industries have been in place in the clinical laboratory for decades. Statistical process control charts are one of the most commonly used methods to monitor quality of a given laboratory process. 1 In this study, we used them to pilot an early detection system of unexpected patterns of occurrences of laboratory values in the hospital. Our primary data consisted of patient critical, or "panic," values. These were originally defined in 1972 and elaborated on in 1990 by Lundberg, 2 a pathologist who observed that very high or low abnormal laboratory values indicated that the patient would die or have irreparable physical damage unless treated immediately.
No study to date has used laboratory critical values to evaluate variations in patient adverse events. We retrospectively analyzed a database of critical values to determine their distribution by hospital unit over time. The data were drawn from the Ohio State University Medical Center Information Warehouse (Columbus) for a 58-month period. Critical values were plotted over time on statistical control charts and analyzed for unusual peaks in monthly occurrence rates. Chart review of individual patient results yielded several predictor variables for the unusual peaks. Of these, occurrence of patient adverse events was the most relevant independent predictor variable for a month with an unusual number of critical values vs a normal month. This result epidemiologically confirms the basic premise of critical value reporting and suggests that the control-chart method of this type could be a new statistical tool to compare clinical activity of different hospital locations at different times.
Quality improvement and patient safety are inseparable in the health care industry. Medical errors can result in disability, decreased quality of life, and death. These potential outcomes underscore the need for continual system improvements and early detection of variations in hospital processes, which could precipitate adverse events. The process-based quality control methods that are becoming standard in most other professional industries have been in place in the clinical laboratory for decades. Statistical process control charts are one of the most commonly used methods to monitor quality of a given laboratory process. 1 In this study, we used them to pilot an early detection system of unexpected patterns of occurrences of laboratory values in the hospital. Our primary data consisted of patient critical, or "panic," values. These were originally defined in 1972 and elaborated on in 1990 by Lundberg, 2 a pathologist who observed that very high or low abnormal laboratory values indicated that the patient would die or have irreparable physical damage unless treated immediately.
The development and improvement in information systems during the past 25 years have led to the ability to produce databases with retrospective and concurrent clinical relevance. 3 In fact, informatics techniques were being advanced as health management and outcomes improvement tools in the early to mid 1980s. 4, 5 Aller 6 argues that it is incumbent on clinical laboratories to systematically archive data, without which outcomes studies and automated patient management efforts are impossible. The present study was undertaken with these historical underpinnings in mind. We conducted a retrospective study using a database of laboratory critical values classified by the hospital unit (nursing station) of origin and by month of occurrence. These data were then used to generate statistical control charts of numbers of critical values per month by analyte and hospital unit. We then "drilled down" on individual patient cases to evaluate potential predictors of the statistical control chart violations we found (ie, months with a statistically significant increase in number of critical values over the expected number).
Materials and Methods
Clinical laboratory data were captured for 58 months in the Ohio State University (OSU) Medical Center (OSUMC) Information Warehouse (IW), beginning in April 2000. All occurrences of critical values were collected for potassium, sodium, chloride, carbon dioxide, inorganic phosphorus, magnesium, calcium, ionized calcium, the international normalized ratio, and partial thromboplastin time. Our study captured data from the main OSU hospital, the James cancer hospital, OSU East hospital, and all associated outpatient clinics. Multiple datasets of all critically high or low laboratory values were generated and then sorted by analyte, hospital location, and month. Information at this level of analysis is deidentified and aggregated. For patients with critical values during the months in which a statistically unusual number of analyte critical values occurred, data were collected through medical chart review without recording patient identifiers on the data collection form. The total number of laboratory tests performed with normal and abnormal results in a given month was also collected to obtain the relative percentages of critical results. The samples used to generate the present study are the individual data sets created from IW data.
From this database, expected values were derived for the number of initial presentations of critical values per month among patients on each hospital unit. The process of screening IW data produced 234 statistical control charts of aggregate data for 18 analytes (international normalized ratio and partial thromboplastin time do not have critical low values; all others have critical high and critical low) and 13 hospital units or nursing station categories.
Each of the 234 charts was analyzed for time-related, unusual statistical events using Minitab statistical software "Individuals and Moving Range (I/MR)" control chart functions (version 13, Minitab, State College, PA). Upper control limits, means, and lower control limits were graphed for the 58-month period (234 times). Unusual statistical event months (ie, control chart violations) occurred when a plotted point was more than 3 SDs from the center line representing the average occurrence level (ie, expected value) of critical values by analyte and location. Thirty-four of these unusual event months were noted out of all 234 control charts. Each of these unusual events represents a month of aggregate critical value data for a particular analyte on a particular hospital unit and may represent results from multiple patients. For example, ❚Figure 1❚ shows 1 of the 234 control charts on which a single "unusual control-chart event" occurred. The event represents a month in which the number of ionized calcium critical values occurring on 1 hospital unit exceeded the expected number of ionized calcium critical values on that unit by more than 3 control chart SDs.
To evaluate the relationship between clinical outcomes and the occurrence of critical values, we undertook a retrospective study wherein data for patients from months in which unusual events occurred (our "case" months) were compared with data for patients from months with no such events (our "control" months). The 34 case months identified in this way were studied through patient chart review. All items of selected clinical and demographic information (potential predictor variables) were collected from the patient charts without recording of patient identifiers on the data collection form. The number of critical values involved in individual case months ranged from 5 to 42 monthly critical values and could be linked to between 1 and 29 distinct patients.
Sample size calculation estimates for valid rate comparisons indicated that 134 patients should be randomly selected from case months (cases) and 134 patients from control months, ie, months with critical values but not an unusual number of them (controls). All control patients were selected from a point in time within 5 months of the case patients and frequency matched on medical care unit. A uniform data collection form was created to capture demographic, behavioral, and clinical data from the 268 patient charts that contained critical values. Operational definitions were created for the independent variables; most are binary. The occurrence of an adverse event is one clinical outcome that was hypothesized to be associated with patients sampled from case months. A patient adverse event was defined as a bleeding episode, prolongation of hospital stay, cerebrovascular accident, cardiac injury, or death. ❚Table 1❚ illustrates the distribution of the patient adverse events that were identified in this study. The dependent variable is whether a patient adverse event occurred during a case (unusual-event) month or a control (normal) month. The study was conducted this way, with unusual-event month or normal month as the dependent variable because IW data had been collected for 5 years without respect to patient population characteristics. It was thus necessary to sample patient charts and use the occurrence of adverse events as a "predictor" of case months (unusual event months = control chart violations). Multiple logistic regression analyses were performed to identify predictor variables for case patients and control patients. Odds ratios with their associated 95% confidence intervals were calculated from the estimated parameters.
This project was funded by an OSUMC Strategic Initiatives grant. The protocol was approved by the OSU Institutional Review Board and was found to be in compliance with the Health Information Portability and Accountability Act (authorization waived).
Results
We concluded, through χ 2 analysis, that the patients in our study were selected from a heterogeneous patient population; equivalently, there was an association between medical care unit risk and an increase in critical value occurrence rates.
Descriptive Statistics
Demographic and risk factor information was collected for 268 case and control patients. Nearly two thirds (60.9%) of all patients in the logistic analysis were male, with a mean age of 58.8 years; the remainder (39.1%) of female patients had a mean age of 63.1 years. With regard to ethnicity, the majority of patients (75.4%) were white, followed by African American (16.9%) and all other races (7.7%). Employment status varied from full-time work (38.6%) to unemployment (9.9%).
Circulatory system diseases alone accounted for 20.9% of all hospitalizations. Among circulatory diseases, the reasons for hospitalization included occlusion of the coronary arteries, congestive heart failure, myocardial infarction, nonspecific chest pain, and stroke (cerebrovascular accident or transient ischemic attack). For respiratory diseases, pneumonia accounted for nearly half (47.6%) of all hospitalizations.
Among digestive system diseases, the leading reasons for hospitalization were gallbladder disease, gastrointestinal bleeding, nonhernia intestinal obstruction, and appendicitis. The leading neoplastic diagnoses were secondary cancers, benign tumor of the uterus, lung cancer, breast cancer, and unspecified benign tumors. Diabetes mellitus accounted for the majority (72.3%) of endocrine disorders. Risk factors, or independent explanatory variables, exhibited most by this population included non-independent functional status (71.9%), hypertension (56.2%), congestive heart failure (28.6%), and current tobacco smoking (21.1%).
Logistic Regression Analyses
A patient adverse event was recorded if it occurred within 2 weeks of the peak in critical value occurrence rate during a case (unusual-event) month. For control (normal) months, the occurrence of an adverse event was monitored for the 2 weeks following the selected month. There were a total of 46 predefined patient adverse events identified in this study. The majority (60.9%) occurred in the case months, with the remainder (39.1%) arising in the control months. The adverse events ranged as follows: death, 14 events; cardiac injury, 11 events; cerebrovascular injury, 9 events; prolongation of hospital stay, 8 events; and major bleeding episode, 4 events.
❚Table 2❚ shows characteristics of the identified case months in the present logistic analysis, including distribution by analyte, hospital unit, and number of distinct patients involved. Logistic analyses evaluated the effects of multiple explanatory variables on whether the patient was selected from a case or a control month. The relationship between the dependent variable (case month or not) and the risk factor of interest (patient adverse event occurrence or not) was stratified by the remaining explanatory variables with some variation in risk across levels of those variables, but no logistic regression interaction terms were statistically significant. Binary logistic regression models were fitted for the remaining explanatory variables. The final logistic regression model contains 7 variables: adverse event occurrence, sex, medical care unit risk, smoking status, age (as a dichotomous variable), number of critical values per patient, and history of a previous myocardial infarction. Adjusted odds ratios with their associated 95% confidence intervals are given in ❚Table 3❚.
Goodness-of-fit was assessed with the HosmerLemeshow χ 2 statistic (7.61; P = .473), indicating that the observed and the predicted counts are close and the model fits the data well. 7 
Discussion
All patients in the study were from the OSUMC. We believe our results are representative of large-scale hospital settings across the country. Before this study, there was no high-level view of the distribution of critical laboratory values by time and location, underscoring the need for similar studies to be performed in other hospital environments nationwide. 
Threats to Validity
All patients "included" in the present study were sampled from the OSUMC hospital system. It is likely that the cases (patients selected from unusual-event months) are representative of the same population that generated the controls (patients selected from normal months). Data on a range of other predictor variables related to the exposure and end point, such as demographic and behavioral variables, were collected. Standardized data collection sheets and well-defined operational definitions should have minimized potential misclassification because objective data were abstracted from patient records. If misclassification exists in this study, it is likely of the nondifferential variety because data collection procedures were identical for both groups of patients. The chemistry and coagulation analyzers at OSUMC were reviewed for quality control testing, recent instrument calibrations, major changes in reagent lot numbers, and performance of current preventive maintenance. All instruments were within acceptable laboratory limits on inspection.
Subgroup analysis was used to examine the relationships between potentially confounding predictor variables and the outcome variable. Multiple regression analysis is one way of controlling for confounding because modeling is used to examine the potential effect of a potential predictor while controlling for the effect of other predictor variables in the model simultaneously. In this study, much consideration was given during the model-building process to identify other potential confounders and include them in the model. Predictor variables changing the crude measure of association by roughly 20% or more were retained in the model. Interaction, or effect modification, occurs when the estimate of effect of "exposure" depends on the level of another predictor in the study base. Interaction was difficult to assess in this study owing to low statistical power. Stratification was used, and variables that seemed to modify effects were tested with logistic regression yielding interaction terms with no statistical significance. This underscores the need for further studies using a much larger sample.
Recommendations
As a screening tool, the proposed control-chart method should be evaluated for sensitivity and specificity and its predictive value (positive and negative). Validation studies need to be performed to authenticate these findings in a prospective manner. The present study used a retrospective approach because of unalterable circumstances; however, to establish legitimacy of this system (the use of IW data) as a sentinel of adverse events, prospective cohort studies must be conducted. Ideally, control-chart violations (case months) would be the predictor of subsequent patient status changes. Such studies The findings of this research need to be verified with other studies using the same and different predictor variables at different-sized hospitals throughout the United States. In addition, the exposure (occurrence of a case month, ie, increased occurrence of critical values) should be stratified, using different levels of loss of statistical control. The pathogenesis of a laboratory critical value does not proceed from a normal value directly to a critical value. Many physiologic events occur within the patient, resulting in detectable elevations and abnormalities in serum analyte levels. 8 This stratification could also show an important dose-response relationship between exposure and outcome.
Closing Remarks
The research topics discussed herein are unique on many levels, and it is, therefore, difficult to find an appropriate body of work that this research responds to. This study is distinctive because it is the first to use patient laboratory critical results, or panic values, as the generator of its primary data set. Since the Lundberg 2 article was published, no known studies have even tested the efficacy of the original reference ranges for his initial analytes, although Aller 6 advocates using large, clinical laboratory databases for just such an activity. It is also unique because it describes a method of surveillance, or a "distant early warning" system, whereby a clinical laboratory can assist in monitoring the rest of the patient care systems within the hospital. The paucity of supporting literature underscores the need for additional analyses on these issues. Further studies are necessary to better explore the efficacy of this proposed system; however, as a forerunner, it may serve as a useful template for future investigations.
Significant findings of this study included several predictor variables for a patient being a case, ie, being selected during a month in which more than the expected number of critical values were reported from his or her medical care unit. The more intuitive predictors included tobacco smoking, advanced age, and previous myocardial infarction. These risk factors have been identified in many other hospital research projects, yet the significance in identifying them in this research calls attention to the usefulness of this proposed system built around critical values. The hospital unit a patient is assigned to is also an important predictor (risk factor) as is the number of laboratory critical values per patient. The method proposed herein, further evaluated and adjusted to each institution's particular needs, should continue to be tested as a potential weapon in the arsenal for patient safety. As currently envisioned, this system is not designed specifically to detect "bad patient care practices" per se, but it can reveal clustering of clinically extreme laboratory values by time and location that would otherwise likely go unobserved. Such clustering may be due to statistical fluctuations in natural morbidity patterns or to shared environmental influences. In either case, the usefulness of this system does not lie in its capacity to prevent adverse events but in its ability to rapidly detect them, facilitating timely investigation when warranted.
